What is the treatment for Bell's palsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bell's Palsy

Primary Treatment: Oral Corticosteroids

Prescribe oral corticosteroids within 72 hours of symptom onset for all patients 16 years and older with Bell's palsy. 1, 2

Recommended Regimens

  • Prednisolone 50 mg daily for 10 days, OR 1, 2
  • Prednisone 60 mg daily for 5 days followed by a 5-day taper 1, 2

Evidence Supporting Corticosteroids

  • 83% complete recovery at 3 months with prednisolone versus 63.6% with placebo 1, 3
  • 94.4% complete recovery at 9 months with prednisolone versus 81.6% with placebo 1, 3
  • Number needed to treat is 6 at 3 months and 8 at 9 months 4

Critical Timing Window

  • Treatment must be initiated within 72 hours of symptom onset 1, 5, 2
  • After 72 hours, steroid benefit is unclear and not supported by high-quality evidence 5
  • Clinical trials demonstrating efficacy specifically enrolled patients within this 72-hour window 5

Antiviral Therapy Considerations

Never prescribe antiviral therapy alone—it is completely ineffective as monotherapy. 1, 2

Combination Therapy (Optional)

  • May offer oral antivirals in addition to corticosteroids within 72 hours as an option 1, 2
  • Valacyclovir 1 g three times daily for 7 days, OR 6
  • Acyclovir 400 mg five times daily for 10 days 1, 6
  • The added benefit is minimal—corticosteroids remain the cornerstone of treatment 1
  • Some evidence suggests modest improvement in synkinesis rates with combination therapy 6, 7

Mandatory Eye Protection

Implement aggressive eye protection immediately for all patients with impaired eye closure to prevent permanent corneal damage. 1, 2

Eye Protection Protocol

  • Lubricating ophthalmic drops every 1-2 hours while awake 1, 2
  • Ophthalmic ointment at bedtime for sustained moisture retention 1, 2
  • Eye patching or taping at night (with careful instruction on proper technique to avoid corneal abrasion) 1, 2
  • Sunglasses for outdoor protection against wind and foreign particles 1, 2
  • Moisture chambers using polyethylene covers for severe cases 1, 2

Urgent Ophthalmology Referral Indications

  • Complete inability to close the eye 1
  • Signs of corneal exposure or damage (eye pain, vision changes, redness, discharge) 1
  • Development of ocular symptoms at any point during recovery 1, 2

Special Populations

Pediatric Patients

  • Children have better prognosis with spontaneous recovery rates up to 90% 2, 6
  • Evidence for corticosteroid benefit in children is inconclusive 1, 2
  • May consider oral corticosteroids on a case-by-case basis with substantial caregiver involvement in shared decision-making 1, 2

Pregnant Women

  • Treat with oral corticosteroids within 72 hours using individualized assessment of benefits and risks 1, 2
  • Eye protection measures are essential and safe in pregnancy 1

Patients with Comorbidities

  • Consider careful benefit-risk assessment for patients with diabetes mellitus, morbid obesity, or previous steroid intolerance 2

Follow-Up and Reassessment

Mandatory Reassessment or Specialist Referral Triggers

  • Incomplete facial recovery at 3 months after symptom onset 1, 5, 2
  • New or worsening neurologic findings at any point 1, 2
  • Development of ocular symptoms at any point 1, 2

Expected Recovery Timeline

  • Most patients begin showing recovery within 2-3 weeks 1, 2
  • Complete recovery typically occurs within 3-4 months 1, 2
  • Approximately 70% of patients with complete paralysis recover fully within 6 months 1, 5
  • Patients with incomplete paralysis have recovery rates up to 94% 1, 5

Long-Term Management for Incomplete Recovery

  • Refer to facial nerve specialist or facial plastic surgeon for evaluation of reconstructive options 1
  • Consider static procedures (eyelid weights, brow lifts, static facial slings) 1
  • Screen for depression and provide psychological support 1

Therapies NOT Recommended

Do not offer the following interventions:

  • Antiviral monotherapy (completely ineffective) 1, 2
  • Surgical decompression (rarely indicated except in specialized cases) 1, 2
  • Acupuncture (poor-quality trials, indeterminate benefit-harm ratio) 1, 2
  • Physical therapy (limited evidence, equilibrium of benefit and harm) 1, 2

Common Pitfalls to Avoid

  • Delaying treatment beyond 72 hours reduces corticosteroid effectiveness 5, 2
  • Using antiviral therapy alone is ineffective and delays appropriate treatment 1, 2
  • Inadequate eye protection can lead to permanent corneal damage 1, 2
  • Failing to refer at 3 months for incomplete recovery delays access to reconstructive options 1, 2
  • Improper eye taping technique can cause corneal abrasion—patients must receive careful instruction 1, 2

Diagnostic Considerations

Initial Assessment

  • Diagnosis requires acute onset of unilateral facial weakness involving the forehead within 72 hours without identifiable cause 1
  • Thorough history and physical examination to exclude trauma, infection, tumor, or stroke 1

When to Order Imaging

  • Routine laboratory testing and imaging are NOT recommended for initial diagnosis 1
  • MRI with and without contrast is indicated for atypical presentations, no recovery after 3 months, or worsening symptoms 1
  • Atypical features requiring imaging include: second paralysis on same side, isolated branch paralysis, other cranial nerve involvement, or bilateral facial weakness 1

References

Guideline

Assessment and Management of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bell's Palsy Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Early treatment with prednisolone or acyclovir in Bell's palsy.

The New England journal of medicine, 2007

Guideline

Treatment of Bell's Palsy at Day 5

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bell Palsy: Rapid Evidence Review.

American family physician, 2023

Research

Outcome of treatment with valacyclovir and prednisone in patients with Bell's palsy.

The Annals of otology, rhinology, and laryngology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.